Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling

Recruiting N/A Interventional Study
Obesity Insulin Sensitivity Muscle Weakness Adiposity Insulin Resistance
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
70 (estimated)
Sponsor
University of Colorado, Denver · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this intervention study is to learn about how weight loss impacts molecular signaling of intermuscular adipose tissue (IMAT) in individuals with obesity. The main question it aims to answer is how inflammatory molecules secreted by IMAT promote muscle insulin resistance and inflammation, and how these same molecules are diminished after weight loss. Following screening visits involving…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Generally healthy men and women aged 18-70 * BMI between 30-40 * Less than 1 hour of exercise per week * Women: 1. may be pre or post menopausal Exclusion Criteria: * Type 1 or Type 2 diabetes * Thyroid disease * History of lung disease * Active use of nicotine * Severe p…
Contacts

Bryan Bergman, PhD

3037243919

bryan.bergman@cuanschutz.edu

CONTACT

Sophia Bowen

3037240487

sophia.bowen@cuanschutz.edu

CONTACT